PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Screening (15 December 2020)
Question Asked
Asked by:
Esther McVey (Conservative)
Answer
The Cambridge University and AstraZeneca Lighthouse Laboratory’s most recent innovation of heat inactivation of samples and the direct to polymerase chain reaction (PCR) process, in conjunction with GSK, accelerates PCR testing and thereby increases the laboratory’s potential capacity whilst reducing processing times. They have also developed novel solutions to some of the logistical challenges faced by the network including the development of a system that allows samples to be delivered in racks direct to the laboratory and data monitoring software to reduce the risks to data uploads.
Answered by:
Helen Whately (Conservative)
5 February 2021
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.